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Linseed hydrogel (LSH) was evaluated by acute toxicity for its potential application in oral drug delivery 
design. White albino mice and rabbits were divided in four groups (I–IV) and different doses of LSH (1, 
2 and 5 g/kg body weight) were given except to the control group (I) that was left untreated. Rabbits were 
monitored for eye irritation, acute dermal toxicity and primary dermal irritation, whereas, body weight, 
food and water consumption, hematology and clinical biochemistry, gross necropsy and histopathology 
of vital organs were scrutinized in mice. LSH was considered safe after eye irritation test as no adverse 
signs or symptoms were seen in the eye. In dermal toxicity and irritation study, skin of treated rabbits 
was found normal in color without any edema or erythema. After oral administration, there was no 
sign of any abnormalities in treated group animals (II–IV). The hematology and clinical biochemistry 
of treated group animals was comparable with the control group. Histopathology of vital organs has 
not shown any lesion or abnormalities. In the light of these outcomes, it can be concluded that LSH is 
not a hazardous biomaterial and could be incorporated as an excipient in oral and dermal preparations. 
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INTRODUCTION
Over the past few decades, enormous progress 
has figured out in the invention and development 
of biomaterials for various biomedical applications 
(Hoffman, 2000). Among these, polysaccharides based 
polymeric biomaterials have drawn appreciable attention 
of the biomedical scientists due to their biocompatibility 
(Dang, Leong, 2006), biodegradability (Jain, Gupta, Jain, 
2007), bioavailability (Mizrahy, Peer, 2012), ease and 
versatility in drug designing and development (Zhang, 
Wardwell, Bader, 2013; Hussain et al., 2011; Hussain 
et al., 2009). These properties also make such naturally 
occurring polysaccharides an integral part of many drug 
delivery systems (Iqbal et al., 2011; Xu et al., 2015; 
Muhammad et al., 2016; Ashraf et al., 2017). 
Due to immense importance of polysaccharides as 
a drug delivery system, it is necessary to evaluate and 
establish the safety profile of these materials. For this 
purpose, toxicological evaluation is carried out to ensure 
their diverse and extensive biomedical applications. 
Depending upon the nature, duration of treatment, route of 
administration and chemical composition of the materials, 
various types (acute, sub-acute, sub-chronic and chronic) 
of toxicity studies are carried out. 
Recently, toxicological studies of polysaccharides 
extracted from Plantago ovata (Erum et al., 2015), 
Mangifera indica (Amien et al., 2015), Araucaria 
heterophylla (Divvela, Duppala, Kolapalli, 2016), 
Curcuma longa (Velusami et al., 2013) have been 
conducted by different researchers. Additionally, chitosan 
and its derivatives are extensively used in various 
biomedical applications and evaluated through toxicity 
studies (Kean, Thanou, 2010; Hu et al., 2011).
Flax (Linum usitatissimum L.) is cultivated to 
get fibers and seeds. Flaxseeds/linseeds are the rich 
source of oil, protein and carbohydrates and have many 
applications in food industry (Oomah, 2001). Linseed 
is rich in polysaccharides which are present in the seed 
coat and mainly composed of rhamnogalacturonan and 
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arabinoxylan (Oomah et al., 1995; Qian et al., 2012). 
Linseed polysaccharides can be easily separated using 
hot water extraction method (Haseeb et al., 2016). In our 
previous work, linseed hydrogel (LSH) has shown high 
swelling capacity, stimuli responsive swelling-deswelling 
behavior and remarkable potential as a sustained release 
material for oral drug delivery system (Haseeb et al., 
2016; Haseeb et al., 2017). Due to widespread potential 
and application of LSH in a various dosage forms, it is 
necessary to investigate the safety profile of LSH. For 
this purpose, acute toxicity study of LSH was carried out 
to establish its safety profile for safe administration and 
development of various drug delivery systems.
MATERIAL AND METHODS
Isolation of linseed hydrogel
Linseed hydrogel (LSH) was isolated by adopting 
the already reported method (Haseeb et al., 2016). Briefly, 
linseeds were thoroughly washed with deionized water 
to remove dust particles. Clean seeds were soaked in 
deionized water for 48 h. Subsequently, seeds were heated 
at 80 ºC for 30 min. Mucilage was excreted from the seeds 
and separated using nylon mesh. Extracted mucilage were 
defatted with n-hexane and washed with deionized water. 
After centrifugation of the mucilage, LSH were settled 
down and separated, dried at 60 ºC for 48 h, passed through 
sieve no. 60 and stored in air tight container in desiccator.
Animals
Swiss albino mice (25–31 g) and albino rabbits 
(1115–1225 g) of either sex bred were obtained from 
the animal house of University of Sargodha, Sargodha, 
Pakistan and thoroughly examined for any symptoms of 
sickness and anomalies. Animals were divided into four 
groups (group I–IV) (n=5) as described in Table I. 
Animals were kept in clean stainless steel cages in 
a 12 h photoperiod (light on at 06:00 and off at 18:00) at 
22 to 25 °C and 40–70% humidity. Mice and rabbits were 
fed with standard laboratory diet and had free access 
to ordinary tap water. All tests conformed to the Good 
Laboratory Practice (GLP) regulations as described by 
United States Food and Drug Administration (USFDA). 
Procedures adopted for acute toxicity studies were in 
accordance with the guidelines of Organization for 
Economic Co-operation and Development (OECD) 
and National Institute of Health for the care and use of 
laboratory animals. The study protocol was approved by 
Pharmacy Research Ethics Committee of University of 
Sargodha, Sargodha, Pakistan. 
Acute oral toxicity
Acute oral toxicity study of LSH was executed in 
Swiss albino mice following the OECD guidelines for 
analysis of chemicals toxicity. At the instigation of the 
study, the weight variation of animals involved was kept 
minimal and should be < ± 20% of the mean weight (Lina, 
Bar, 2004). After overnight fasting, LSH mixed with food 
was orally administered to mice of groups II, III and IV 
as single oral dose of 1, 2 and 5 g/kg body weight (bw), 
respectively (Table I). The dose of LSH was according 
to criteria for excipient toxicity testing and was more 
than estimated daily intake of excipient (George, Shipp, 
2000). The mice were observed in detail for any indication 
of toxic effect, mortality, ill health and any reaction to 
treatment such as changes in fur, skin, mucus membranes, 
eyes, behavior pattern, tremors, salivation, diarrhea, sleep 
and coma within the first six hours after the treatment and 
daily for a period of 14 days.
Primary eye irritation
This study was carried out in five Albino rabbits. 
Animals were thoroughly examined for any abnormalities 
according to Draize scale for eye lesions (Draize, 1944). 
A suspension of LSH in water (10 mg/10 mL) was drop-
casted into the conjunctival sac of the right eye of each 
rabbit. Upper and lower lids were kept together with 
fingers for some time in order to reduce the risk of any 
loss of the test material. For comparison, the left eye of 
each rabbit was remained untreated and used as a control. 
After LSH administration, eyes were examined after 1, 
24, 48, and 72 h for any lacrimation, redness, swelling and 
TABLE I - Group scheme for acute oral toxicity study of LSH in mice
Group I Group II Group III Group IV
Control given only standard 
diet 
Treated with LSH (1 g/kg bw) 
ground and mixed with diet 
Treated with LSH (2 g/kg bw) 
ground and mixed with diet
Treated with LSH (5 g/kg bw) 
ground and mixed with diet
bw: body weight
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corneal and pupil irritation. Primary eye irritation score 
was determined with maximum mean total score (MMTS) 
as described by Kay and Calandra (Kay, Calandra, 1962). 
Ocular lesion was classified according to the Draize scale 
for scoring eye lesions (Draize, 1944). 
Acute dermal toxicity
Five white albino rabbits were used for acute dermal 
toxicity testing. Rabbits were thoroughly examined for 
health and skin abnormalities before and after removal of 
hair from the back of these rabbits. Thick paste of ground 
LSH (500 mg) in deionized water was prepared and 
applied on a 4 ply gauze pad (4 in × 4 in). Prepared gauze 
pad was placed on the skin of rabbit and wrapped with 
Micropore™ tape (3 inch wide) to avoid displacement 
of the pad. Rabbits were allowed to move freely in their 
respective cages and observed them for any behavioral 
changes for next few hours. After 24 h, the pads were 
carefully removed from the skin and the site of application 
was observed for any color changes in skin or presence of 
rashes etc. Rabbits were kept under observation for next 
14 days and observed for weight gain or loss, mortality, 
sign of behavioral changes, any changes in skin, fur, 
eyes and mucous membrane, diarrhea, salivation, coma, 
convulsions and tremors (Saiyad et al., 2015). 
Primary dermal irritation study
Five adult, young and non-pregnant female albino 
rabbits were selected to carry out primary dermal 
irritation study. Hairs from the back of rabbits were 
removed by clipping the dorsal and trunk area. Skin of 
rabbits was examined for abnormalities before and after 
the removal of hairs and no pre-existing irritation or 
lesion on the skin was observed. To apply test material 
on the skin, LSH (500 mg) was moistened with deionized 
water to make a thick paste and applied on an area of 
approximately 6 cm2. Test area was covered with gauze 
pad and protected from dislocation with the help of 
suitable semi-occlusive dressing. After 4 h, dressing was 
removed and test site was gently cleaned from residual 
test material, observed and score was recorded at 1, 24, 
48 and 72 h after removal of dressing according to the 
Draize scoring system (Kay, Calandra, 1962). Irritancy 
was classified by adding the average edema and erythema 
scores for 1, 24, 48 and 72 h scoring intervals and 
dividing by the number of evaluation intervals (Saiyad 
et al., 2015). The calculated Primary Dermal Irritation 
Index (PDII) was classified according to the descriptive 
rating (Sreejayan et al., 2010).
Body weight 
The body weights of mice were recorded before 
treatment, at day 1, 2, 3, 5, 7 and 14 of treatment. Mean 
body weight was calculated for each group. 
Food and water consumption
The amount of food and water consumed by mice 
before treatment, at day 1, 2, 3, 5, 7 and 14 was measured 
and compared with control to observe the influence of 
LSH intake on these parameters. These day intervals 
were selected to observe and record a more precise and 
accurate values.
Hematology and clinical biochemistry
On day 15, blood samples were collected from the 
overnight (about 12 h) fasted mice of each group into 
lithium heparin or K2-EDTA containing tubes. Blood 
samples were analyzed for hemoglobin, white blood 
cells count, red blood cells count, platelets, monocytes, 
neutrophils, lymphocytes, mean corpuscular volume 
(MCV), mean corpuscular hemoglobin (MCH) and mean 
corpuscular hemoglobin concentration (MCHC).
Blood plasma was also analyzed for alanine 
aminotransferase (ALT), aspartate aminotransferase 
(AST), creatinine, urea, uric acid, cholesterol and 
triglycerides.
Gross necropsy and histopathology
At the end of day 14, mice of each group were 
sacrificed. Gross necropsy of all vital organs (heart, 
liver, lung, kidney, stomach, intestine and spleen) was 
carried out. Organs were weighed and relative organ body 
weight was calculated. Organs were preserved in neutral 
buffered formalin (10% v/v). Tissues were sliced to 4-5 µm 
thickness and histopathology was performed after staining 
with hematoxylin-eosin. 
Statistics
The difference among the numerical values of control 
group and different treated groups were analyzed through 
one way analysis of variance (ANOVA) followed by 
Student’s t-test using statistical analyses software, Minitab 
11. One way ANOVA (Turkeys multiple comparison test) 
and probability value < 0.05 was considered as statistically 
significant. The level of significance was set at p < 0.05. 
All values were expressed as mean ± S.D. 
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RESULTS AND DISCUSSION
Acute oral toxicity study in mice
In acute toxicity study, a single oral dose of LSH 
was given to three groups (group II, III and IV) of male 
albino mice (Table I). At the end of day 14, all animals 
were alive, active and healthy. No other abnormalities 
were seen including behavioral changes, pharmacological 
adverse effects and gross toxicities during the 14 day study 
period. Food intake was less after day 1 as compared to 
remaining days (slight decrease in the body weight in the 
animal of treated groups was observed at day 1 which 
might be due to less food intake as LSH intake may feel 
the fullness of stomach). Results have indicated that the 
acute oral lethal dose (LD50) of LSH is greater than 5 g/kg 
bw for male albino mice. 
Primary eye irritation
To find out the primary eye irritation, LSH suspension 
was instilled in the eye of rabbit. Corneal opacity, iritis, 
conjunctivitis and severity (MMTS) of treated eye was 
monitored. No sign of any abnormality was seen during 72 
h in all groups and assigned 0 score except group II. Eye 
of one animal in group II exhibited conjunctival discharge 
that was cured within 24 h. The score was assigned 2.0 
and 1.0 after 1 h and 24 h, respectively according to 
Kay and Calandra eye irritation scale (Kay, Calandra, 
1962). Severity of the condition (MMTS) in group II was 
0.67 and 0.33 after 1 h and 24 h, respectively. No other 
adverse effects and symptoms were seen. Therefore, the 
conjunctival discharge was classified as accidental and 
overall LSH was found to be nonirritating to the eye. 
Acute dermal toxicity 
Acute dermal toxicity study was carried out in male 
albino rabbits. Single topical application of three different 
doses of LSH (1, 2 and 5 g/kg bw) were applied on three 
groups of rabbits. All animals survived, gained weight and 
did not find any other clinical findings or abnormalities 
during the whole course of study. It is concluded that the 
acute dermal toxic dose was greater than 5 g/kg body 
weight.
Primary dermal irritation study 
Primary dermal irritation study was conducted to 
evaluate the potential of LSH irritancy on a single topical 
application. No erythema or edema was found on the skin 
of treated animal over the course of 14 days. Primary 
dermal irritation index was calculated as 0.0 indicating 
the LSH as a non-irritating material to the skin.
Body weight study 
Results of body weight study are summarized in 
Table II. It was noted that there are gradually increase in 
mean body weight of the control group during the whole 
study period. A decrease in body weight of group II, group 
III and group IV was observed at day 1 while weight gain 
in treated mice was noticed at day 7 and 14. 
Food and water consumption
Food and water intake of each group was measured 
on day 1, 2, 3, 5, 7 and 14. Results have indicated that 
there was no significant difference in food and water 
consumption between control group animals and treated 
animals during the whole study period with exception of 
day 1 (Table II). A significant decrease in the food and 
water intake was noted for group I, group II and group III 
on day 1 which was normalized as the study proceeded. 
Hematology and clinical biochemistry
Hematological parameters of each group were found 
to be normal and they are comparable with the control 
group (group I) as mentioned in Table III. Liver, kidney 
and lipid profiles were also determined and results are 
found to be normal. All values are comparable with the 
animals of control group as mentioned in Table IV.
Gross necropsy and histopathology
Macroscopic analysis of the mice of each group was 
performed and did not find LSH-related abnormalities 
(Table V). All vital organs were remove and weighed 
separately. Results have indicated that no significant 
variations in relative organ body weight of all vital organs 
when compared with the mice of control group. 
CONCLUSION
Considering the outcomes of different parameters 
investigated during acute toxicology study, it could be 
deduced that LSH is a safe material for use as an excipient 
in oral drug delivery system. LSH has met and fulfilled 
the safety criteria of all parameters investigated in acute 
toxicity evaluation and regarded as a safe material for 
biomedical applications. LD50 for LSH was estimated to be 
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TABLE II - Observations of body weight, water and food intake study of LSH
Observations Group I Group II Group III Group IV
Signs of illness NIL NIL NIL NIL
Body weight (g)
Pretreatment 26.4 ± 2.2 28.8 ± 1.8 26.1 ± 2.2 27.7 ± 1.5
Day 1 26.5 ± 1.4 28.7 ± 1.5 26.0 ± 1.9 27.4 ± 3.5
Day 2 27.6 ± 1.2 29.1 ± 1.9 26.2± 1.1 27.5 ± 3.5
Day 3 28.0 ± 1.8 29.8 ± 1.1 26.5 ± 0.9 27.7 ± 3.5
Day 5 28.4* ± 2.7 30.1 ± 2.2 27.2 ± 2.0 28.8* ± 3.5
Day 7 28.5* ± 2.4 30.4* ± 1.8 27.6* ± 2.8 29.4* ± 2.5
Day 14 28.8* ± 2.0 30.8* ± 2.8 28.4* ± 2.0 29.6* ± 1.8
Water intake (mL)
Pretreatment 10.4 ± 1.0 12.2 ± 0.5 11.1 ± 2.1 11.7 ± 1.5
Day 1 10.8 ± 1.5 12.4 ± 1.5 11.6 ± 1.5 12.3 ± 1.7
Day 2 11.5 ± 1.1 12.6 ± 0.5 12.0 ± 2.1 12.6 ± 1.1
Day 3 12.8 ± 0.8 12.5 ± 1.3 12.3 ± 1.8 12.7 ± 1.1
Day 5 13.1* ± 1.8 13.3 ± 1.5 12.8* ± 1.0 12.9 ± 0.7
Day 7 13.0* ± 2.0 13.7* ± 2.0 13.0* ± 2.5 13.0 ± 2.3
Day 14 13.2* ± 1.5 13.9* ± 1.5 13.2* ± 1.5 13.2* ± 2.5
Food intake (g)
Pretreatment 3.4 ± 1.0 3.1 ± 1.5 3.6 ± 2.1 3.8 ± 1.6
Day 1 2.7 ± 1.5 2.4 ± 2.1 1.8* ± 1.1 1.1* ± 1.7
Day 2 3.2 ± 1.9 2.7 ± 2.1 2.3* ± 0.7 2.0* ± 2.1
Day 3 3.8 ± 1.0 2.9 ± 1.1 3.0 ± 1.2 2.3* ± 1.3
Day 5 3.6 ± 1.3 3.5 ± 1.4 3.2 ± 1.6 3.2 ± 0.7
Day 7 4.0 ± 1.0 4.0 ± 1.9 3.8 ± 0.5 3.6 ± 0.9
Day 14 3.8 ± 1.5 3.8 ± 1.3 4.3 ± 2.1 4.2 ± 1.1
Body weight, water and food intake are expressed as mean ± S.D. *P < 0.05 as significant difference when compared to control.
TABLE III - Biochemical blood analysis of control and LSH treated mice
Hematology Group I Group II Group III Group IV
Hb (g/dL) 11.6 ± 0.8 12.1 ± 1.6 13.7 ± 1.6 13.5 ± 1.4
WBCs (103/µL) 4.2 ± 0.3 5.1 ± 0.4 5.9 ± 1.2 6.5 ± 0.5
RBCs (106/µL) 8.28 ± 0.23 8.39 ± 0.45 8.32 ± 0.35 8.15 ± 0.23
Platelets (103/µL) 549.7 ± 2.9 667.2 ± 3.9 678.6 ± 5.5 709.6 ± 4.1
Monocytes (%) 2.1 ± 0.02 2.3 ± 0.01 2.5 ± 0.01 2.2 ± 0.02
Neutrophils (%) 12.8 ± 0.5 13.5 ± 0.3 12.9 ± 0.9 13.8 ± 0.02
Lymphocytes (%) 83.3 ± 2.1 82.3 ± 1.5 84.6 ± 2.1 82.9 ± 1.3
MCV 45.8 ± 1.5 45.9 ± 2.1 51.4 ± 1.4 53.5 ± 1.4
MCH 14.5 ± 0.5 16.0 ± 0.8 15.7 ± 1.0 14.4 ± 1.2
MCHC (g/dL) 28.7 ± 0.3 30.4 ± 0.7 29.6 ± 1.5 31.6 ± 1.1
MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration. 
All values are expressed as mean ± S.D.
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higher than 5 g/kg bw and to find out LD50 more precisely, 
further investigations are recommended. 
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